and Chinese Entecavir industry Report 2015 with Feasibility Study of Future Projects

1
Investigation Report on China Entecavir Market,
2010-2019
View Complete Report _at_ http//www.rnrmarketresearc
h.com/investigation-report-on-china-entecavir-mark
et-2010-2019-market-report.html .
Published By -gt China Research and Intelligence
No. of Pages -gt 30
2
Investigation Report on China Entecavir Market,
2010-2019

• The number of hypertension patients in China is
  estimated to surpass 300 million with one in
  three adults suffering from it. Out of all the
  dyazides, angiotension receptor blocker (ARB) is
  among a new generation which grows fast. Ever
  since the appearance of losartan which has been
  first applied in the clinic, 8 kinds of similar
  drugs have come out for sale and there are also 5
  kinds of generic drugs in China. In recent years,
  telmisartan could be said as the fastest-growing
  kind of dyazide. First developed by
  Boehringer-Ingelheim (Germany) and first marketed
  in the US in 1999 under the trade name of
  Micardis, telmisartan is an oral drug for the
  treatment of essential hypertension which should
  be taken once a day. It was marketed by
  Boehringer-Ingelheim under the trade name of
  Micardis and by Glaxo Wellcome plc under the
  trade name of Pritor in Germany in the same year.
  Telmisartan entered the Philippines in Dec. 1999
  and Australia, Belgium, Britain in 2000. In 2013,
  its sales value surpassed USD 3 billion in the
  world. The patent of telmisartan expired in 2014.
  The active pharmaceutical ingredients (APIs) and
  preparations of telmisartan were introduced by
  Boehringer-Ingelheim into China for sales at the
  end of 2000. After entering China, telmisartan
  grows fast with annual sales value rising from
  less than CNY 13 million in 2005 to CNY 200
  million in 2014 and CAGR during this period
  reaching up to 35.8 despite a slight fall in
  2014. Currently, telmisartan in the Chinese
  market mainly come from the following companies
  Boehringer-Ingelheim (Germany), China Resources
  Double Crane Pharmaceutical Co., Ltd, Yichang
  Changjiang Pharmaceutical Co., Ltd, Wanbang
  Biopharmaceuticals and Hainan Selection
  Pharmaceutical Co., Ltd, among which
  Boehringer-Ingelheim (Germany) has the largest
  market share of over 80, sales value in 2014
  reaching up to CNY 167 million.
• Get discount on the Report _at_ http//www.rnrmarket
  research.com/contacts/discount?rname396964

3
Investigation Report on China Entecavir Market,
2010-2019
Table of Contents 1 Related Concepts of
Entecavir1.1 Indication1.2 Sales Status in
Global Market 2 Market Profile of Entecavir in
China2.1 Patent and Approval Status of Entecavir
in China2.2 Major Manufacturers2.3 Market
Size 3 Survey on Sales Status of Entecavir in
China, 2010-20143.1 Sales Value3.1.1 Overall
Sales Value3.1.2 Sales Value by Regions3.2
Sales Volume3.2.1 Overall Sales Volume3.2.2
Sales Volume by Regions 4 Survey on Market Share
of Major Manufacturers of Entecavir in China,
2010-20144.1 Market Share by Sales Value4.2
Market Share by Sales Volume
4
Investigation Report on China Entecavir Market,
2010-2019
5 Survey on Dosage Forms of Entecavir in China,
2010-20145.1 Share of Different Dosage Forms by
Sales Value5.2 Share of Different Dosage Forms
by Sales Volume 6 Reference Price of Entecavir in
China in 20146.1 Sino-American Shanghai Squibb
Pharmaceuticals Ltd (Trade Name Baraclude)6.2
Sichuan Haisco Pharmaceutical Co., Ltd (Trade
Name Gan Bei Qing)6.3 Shandong Lukang
Pharmaceutical Co., Ltd (Trade Name Mu
Chang)6.4 Chia Tai Tianqing Pharmaceutical Group
Co., Ltd (Trade Name Run Zhong)6.5 Jiangxi
Qingfeng Pharmacy Co., Ltd (Trade Name Wei Li
Qing)6.6 Fujian Cosunter Pharmaceutical Co., Ltd
(Trade Name En Gan Ding)6.7 Dawnrays
Pharmaceutical Limited (Trade Name
Leiyide) 7Major Manufacturers of Entecavir in
Chinese Market, 2010-20147.1 Sino-American
Shanghai Squibb Pharmaceuticals Ltd7.2 Chia Tai
Tianqing Pharmaceutical Group Co., Ltd7.3
Jiangxi Qingfeng Pharmacy Co., Ltd7.4 Fujian
Cosunter Pharmaceutical Co., Ltd7.5 Dawnrays
Pharmaceutical Limited 8 Market Outlook of
Entecavir in China, 2015-20198.1 Forecast of
Market Size8.2 Forecast of Competitive
Landscape Single User License of the Report is
Available at USD 2000, Buy the Report _at_
http//www.rnrmarketresearch.com/contacts/purchase
?rname396964 .
5
Investigation Report on China Entecavir Market,
2010-2019
List of Charts Chart Patent Status of Entecavir
in ChinaChart Approval Information of Entecavir
in ChinaChart Sales Status of Entecavir in
China, 2010-2014Chart Sales Value of Entecavir
in China, 2010-2014Chart Sales Value of
Entecavir in Some Regions in China,
2010-2014Chart Sales Volume of Entecavir in
China, 2010-2014Chart Market Share of TOP5
Manufacturers of Entecavir for Sales Value in
China, 2010-2014Chart Sales Value and Market
Share of Entecavir Made by Shanghai Squibb in
China, 2010-2014Chart Sales Value and Market
Share of Entecavir Made by Chia Tai Tianqing in
China, 2010-2014Chart Sales Value and Market
Share of Entecavir Made by Dawnrays in China,
2010-2014Chart Sales Value and Market Share of
Entecavir Made by Jiangxi Qingfeng in China,
2010-2014Chart Sales Value and Market Share of
Entecavir Made by Fujian Cosunter in China,
2010-2014Chart Sales Value and Market Share of
Entecavir Made by Other Manufacturers in China,
2010-2014Chart Sales Value and Market Share of
Entecavir Capsules in China, 2010-2014Chart
Sales Value and Market Share of Entecavir Tablets
in China, 2010-2014Chart Price of Entecavir Made
by Sino-American Shanghai Squibb Pharmaceuticals
Ltd in Some Chinese Cities in 2014Chart Price of
Entecavir Made by Sichuan Haisco Pharmaceutical
Co., Ltd in Some Chinese Cities in 2014
6
Investigation Report on China Entecavir Market,
2010-2019
Single User License US 2000 Multi User
License US 3000 Purchase This Report _at_
http//www.rnrmarketresearch.com/contacts/purchase
?rname396964 . About Us Rnrmarketresearch.com
is your single source for all market research
needs. Our database includes 100,000 market
research reports from over 95 leading g6lobal
publishers in-depth market research studies of
over 5000 micro markets. We offer you
customization options on reports by custom
reports through MarketsandMarkets.com. With
comprehensive information about the publishers
and the industries for which they publish market
research reports, we help you in your purchase
decision by mapping your information needs with
our huge collection of reports. We provide 24/7
online and offline support to our customers. On
rnrmarketresearch.com, you can buy market
research reports by 1. Publishers 2.
Country 3. Categories/Industries 4. Newly
Published Reports / Latest Reports Contact us
for your special interest needs and we will get
in touch within 24hrs to help you find the market
research report you need. With our expertise and
research offerings, we ensure we deliver on all
your requirements, whether youre looking for
industry analysis or market trends or anything
else, first time and every time!    
Email us _at_ sales_at_rnrmarketresearch.com Call us
1 888 391 5441